SH3BGRL Antibodies

Santa Cruz Biotechnology offers a broad range of SH3BGRL monoclonal antibodies for investigating SH3BGRL in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SH3BGRL, or SH3 domain-binding glutamic acid-rich protein-like, participates in the regulation of cellular signaling pathways and influences cellular growth and differentiation. Research has shown that SH3BGRL maintains cellular homeostasis through multiple molecular mechanisms. Current studies indicate that SH3BGRL expression levels vary significantly across different tissue types. Investigating SH3BGRL activity has revealed its significance in cancer development and progression. Understanding SH3BGRL function continues to provide valuable insights for developing new therapeutic strategies. Research utilizing SH3BGRL monoclonal antibodies from Santa Cruz Biotechnology enables scientists to advance cellular and molecular biology knowledge, contributing to potential breakthroughs in disease treatment.